In light of the global expansion of malaria into Central America, Florida, and Texas in 2023, the results of a landmark study confirm the benefits of combining the RTS,S/AS01E (RTS,S) (Mosquirix™) malaria vaccine with antimalarial drugs.
Long COVID May Affect More Patients Than Previously Thought
A number of patients with postviral syndrome after suspected COVID-19 have immune responses to SARS-CoV-2